Corporate Banner
Satellite Banner
Pharma Outsourcing
Scientific Community
Become a Member | Sign in
Home>Events>This Event
  Events - June 2014

Drug Discovery & Development (DDD2014)

17 Jun 2014 - 18 Jun 2014 - Online Event

Bookmark and Share

SELECTBIO is pleased to invite you to attend the first of our innovative online conferences; Drug Discovery & Development (DDD 2014). Using a pioneering new platform especially developed for scientific events, this event will be broadcast to your PC or mobile device on 17th-18th June 2014.

During this event, the hottest topics in Drug Discovery will be addressed in a webinar-style auditorium with the opportunity for live Q&A at the end of each talk. Featuring an array of leading international speakers, this event aims to provide you with an insight into the latest developments in the design and development of drugs. Focus will be given to current developments in screening design, assay technology and compound management, as well as the emerging use of nanotechnology for drug delivery. Presentations will also highlight the increasing importance that academic centres play in drug discovery efforts, including drug repurposing and drug discovery for orphan diseases.
Benefits of attending this online event:

-    Opportunity to view posters, including an interactive session with the poster presenters.
-    Access to a virtual exhibit hall, enabling you to catch up with the latest technological developments in the industry via video, downloadable applications, brochures and interaction with booth staff.
-    View others in attendance and chat with them privately or in open forums.
-    No costs! No expensive flights, hotels or delegate fees.
-    Come & go as you please to fit around your busy life - you can attend at home or work using a PC or mobile device.

You can present your research on a poster while attending the meeting. Submit an abstract for consideration now!  Poster Submission Deadline: 06 June 2014

Further information
Scientific News
Lucentis Effective for Proliferative Diabetic Retinopathy
NIH-funded clinical trial marks first major advance in therapy in 40 years.
Blocking the Transmission Of Malaria Parasites
Vaccine candidate administered for the first time in humans in a phase I clinical trial led by Oxford University’s Jenner Institute, with partners Imaxio and GSK.
First Therapy Appearing to Reverse Decline in Parkinson’s
An FDA-approved drug for leukemia improved cognition, motor skills and non-motor function in patients with Parkinson’s disease and Lewy body dementia in a small clinical trial, say researchers at Georgetown University Medical Center (GUMC).
Gene Therapy Staves Off Blindness from Retinitis Pigmentosa in Canine Model
NIH-funded study suggests therapeutic window may extend to later-stage disease.
Treatment for Rare Bleeding Disorder is Effective
Researchers in Manchester have demonstrated for the first time the relative safety and effectiveness of treatment, eltrombopag, in children with persistent or chronic immune thrombocytopenia (ITP), as part of an international duo of studies.
HIV Vaccine Human Trials Begin
Baltimore-based Institute has begun enrolling volunteers for initial phase 1 clinical trials.
New Therapy Reduces Symptoms of Inherited Enzyme Deficiency
A phase three clinical trial of a new enzyme replacement medication, sebelipase alfa, showed a reduction in multiple disease-related symptoms in children and adults with lysosomal acid lipase deficiency, an inherited enzyme deficiency that can result in scarring of the liver and high cholesterol.
Fixing Holes in the Heart Without Invasive Surgery
UV-light enabled catheter is a medical device which represents a major shift in how cardiac defects are repaired.
Atriva Therapeutics GmbH Develops Innovative Flu Drug
Highly effective against seasonal and pandemic influenza.
Study Removes Cancer Doubt for Multiple Sclerosis Drug
Researchers from Queen Mary University of London are calling on the medical community to reconsider developing a known drug to treat people with relapsing Multiple sclerosis after new evidence shows it does not increase the risk of cancer as previously thought.
Scroll Up
Scroll Down

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos